Prospective Validation of the SWEET Tool for Pre-diction of Preintervention ERCP Procedure Time.
Recruiting
Observational Study
Endoscopic Retrograde Cholangio-Pancreatography
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 363 (estimated)
- Sponsor
- Universitair Ziekenhuis Brussel · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Endoscopic retrograde cholangiopancreatography (ERCP) is a frequently performed procedure worldwide. The procedure combines endoscopy and X-ray imaging to diagnose and treat problems in the bile and pancreatic ducts, most commonly stones or strictures.
Until the recent publication of Waldthaler et al., there was little evidence about what patient- and procedure-related factors determine a priori …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \> 18 years
* First or redo-ERCP
* Intraductal endoscopy
* ERCPs performed by fellows under supervision
Exclusion Criteria:
* ERCPs in altered anatomy
* ERCPs combined with therapeutic EUS interventions
Contacts